Prognostic Value of SUR in Patients With Trimodality Treatment of Locally Advanced Esophageal Carcinoma

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.117.207670
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Prognostic Value of Monocarboxylate Transporter 4 in Patients With Esophageal Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2018English

Is Surgery Still Part of Local Therapy in Patients With Locally Advanced Esophageal Carcinoma?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2007English

Prognostic Value of Pretherapeutic Tumor-To-Blood Standardized Uptake Ratio in Patients With Esophageal Carcinoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Treatment of the Advanced Esophageal Carcinoma

Nihon Kikan Shokudoka Gakkai Kaiho
1977English

Neoadjuvant vs Definitive Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Patients

World Journal of Surgical Oncology
SurgeryOncology
2018English

The Current Status of Multimodality Treatment for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Value and Application of Trimodality Therapy or Definitive Concurrent Chemoradiotherapy in Thoracic Esophageal Squamous Cell Carcinoma

Cancer
Cancer ResearchOncology
2017English

The Prognostic Value of B7-H6 in Esophageal Squamous Cell Carcinoma

Scientific Reports
Multidisciplinary
2019English

Prognostic Value of CA125 Regression Following Surgery and Chemotherapy in Patients With Advanced Epithelial Ovarian Carcinoma.

Juntendo Medical Journal
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy